Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Comparative efficacy and safety of protocol-defined 2-year versus indefinite immunotherapy strategies for advanced non-small-cell lung cancer: A systematic review and network meta-analysis

The optimal duration of immune checkpoint inhibitor (ICI)-based therapy for advanced non-small-cell lung cancer (NSCLC) remains uncertain. To compare first-line ICI-based regimens with a protocol-defined maximum treatment duration of approximately 2 years versus indefinite treatment. Systematic review...

Jia-Mei Yu, Qing Ling, Yi Jiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.